Search Results - "atherothrombosis"

Refine Results
  1. 1

    THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS by O. V. Gaisenok

    Published 2016-01-01

    Current issues of atherothrombosis prevention and treatment optimization with antiplatelet therapy in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet therapy is focused on, especially in the aspect of the problem of aspirin resistance. Chronology...

    Full description

    Subjects: “…atherothrombosis…”
    Get full text
    Article
  2. 2

    ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS by A. V. Govorin, A. P. Filev

    Published 2015-12-01

    The results of large-scale clinical trials have convincingly demonstrated the effectiveness of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety of different ASA formulations have been continuing. Magnesium hydroxide included in combined...

    Full description

    Subjects: Get full text
    Article
  3. 3

    ПОСЛЕДНЯЯ БОЛЕЗНЬ ЛЮДОВИКА XIV by Н. Н. Боровков, Н. Ю. Боровкова

    Published 2014-12-01

    On the basis of historical documents, memoirs of contemporaries, the authors analyze the clinic and development of atherothrombosis the left femoral artery complicated by gangrene of the limb from which sufferd the well-known historical figures — the king of France Louis XIV. The authors clarify the...

    Full description

    Subjects: Get full text
    Article
  4. 4

    Factors determining homocysteine levels in Russian patients with stable coronary heart disease by O. O. Shakhmatova, A. L. Komarov, D. V. Rebrikov, M. A. Turchaninova, T. I. Kotkina, A. V. Bolvacheva, A. D. Deev, A. B. Dobrovolsky, E. V. Titaeva, E. A. Panchenko

    Published 2010-08-01

    Aim. To identify the factors determining homocysteine (HMC) levels in Russian patients with stable coronary heart disease (CHD). Material and methods. The study included 506 patients (388 men; mean age 59,4±12,2 years) with stable CHD. Classical risk factors (RFs) of cardiovascular disease (CVD), re...

    Full description

    Subjects: Get full text
    Article
  5. 5

    Comparative study of specific activity of rectal suppositories with clopidogrel by I. L. Kechyn, V. V. Hladyshev, O. L. Drozdov, O. B. Kharaponova, S. A. Hladysheva

    Published 2021-12-01

    One of the most effective platelet antiaggregants is clopidogrel, inhibiting platelet activation by selectively binding adenosine diphosphate (ADP) with specific receptors. However, in a number of clinical situations it is necessary to have a pronounced antithrombotic effect in the shortest possible...

    Full description

    Subjects: “…atherothrombosis…”
    Get full text
    Article
  6. 6

    Factors influencing cardiovascular mortality in Russian population by S. A. Shalnova, A. D. Deev, R. G. Oganov

    Published 2005-02-01

    According to the results of prospective studies performed at the State Research Center for Preventive Medicine, the data on main cardiovascular risk factors prevalence, their role in total cardiovascular mortality, coronary heart disease and stroke mortality in Russian population are presented. It i...

    Full description

    Subjects: Get full text
    Article
  7. 7

    ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE by M. G. Bubnova

    Published 2010-08-01

    This review is focused on the main aspects of aspirin therapy in the prevention of various atherothrombosis manifestations and coronary heart disease (CVD). The major mechanism of aspirin action is explained, and additional aspirin benefits, unrelated to its anti-aggregant activity, are described. C...

    Full description

    Subjects: “…atherothrombosis…”
    Get full text
    Article
  8. 8

    The role of modern antithrombotic agents in cardiovascular disease prevention by O. M. Drapkina, A. V. Klimenkov, V. T. Ivashkin

    Published 1970-01-01

    Atherosclerosis is one of the most urgent problems in modern cardiology. Atherosclerosis instability and coronary heart disease clinical course are based on plaque ulceration, rupture, and atherothrombosis. Atherothrombosis causes 28% of all deaths worldwide. Therefore, usage of medications targeted...

    Full description

    Subjects: Get full text
    Article
  9. 9

    Hemostasis protein-coding genes, peripheral hemostasis parameters, and atherothrombosis predisposition in patients with cardiovascular disease by G. I. Lifshits, S. T. Danilkina, E. V. Guskova, E. N. Voronina, M. L. Filipenko

    Published 2011-08-01

    Aim. To study the associations between polymorphic variants of hemostasis protein-coding genes, hemostasis system functioning, and atherothrombosis development in patients with cardiovascular disease (CVD). Material and methods. The study included 76 patients. Polymorphic gene marker alleles were an...

    Full description

    Subjects: “…atherothrombosis…”
    Get full text
    Article
  10. 10

    Prevention of primary stroke in adults and children by T. L. Vizilo, T. V. Poponnikova, I. F. Fedoseeva

    Published 2021-06-01

    Modern views of stroke prevention are discussed. Universally recognized strategies of stroke prevention are analyzed and new approaches to preventive treatment of cerebral circulation disorders are proposed.

    Subjects: Get full text
    Article
  11. 11

    Acute coronary syndrome: how to reduce the residual inflammatory risk? by V. I. Shalnev

    Published 2020-03-01

    Inflammatory mediators play an important role in the pathogenesis of acute coronary syndrome (ACS). The results of experimental and randomized clinical trials on the role of various inflammation inhibitors in the treatment of coronary artery disease (CAD), in particular CANTOS and COLCOT, mark a new...

    Full description

    Subjects: Get full text
    Article
  12. 12

    PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? by I. V. Zotova, D. A. Zateyshchikov

    Published 2016-01-01

    Arterial hypertension (HT) is a reason for raising a question about need for antithrombotic therapy. At the same time, increased blood pressure associated with an increased risk of hemorrhagic complications. Possible ways to minimize the hemorrhagic risk in different groups of hypertensive patients...

    Full description

    Subjects: Get full text
    Article
  13. 13

    Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases by O. I. Afanasieva, S. N. Pokrovsky

    Published 2019-06-01

    Lipoprotein(a) (Lp(a)) is a complex supramolecular complex belonging to apoB100 lipoproteins. Lp(a) consists of a particle of similar low-density lipoprotein, in which the apolipoprotein molecule В100 is covalently linked by a disulfide bond with a unique polymorphic apolipoprotein(a) molecule. The...

    Full description

    Subjects: Get full text
    Article
  14. 14

    RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME AND HIGH PLASMA LEVELS OF D-DIMER by A. V. Panina, N. F. Puchinyan, Ya. P. Dovgalevskyi, N. V. Furman, P. V. Dolotovskaya, L. I. Malinova

    Published 2013-08-01

    Aim. To study the association of plasma D-dimer levels and the risk of thrombotic events in patients hospitalised with acute coronary syndrome (ACS).Material and methods. The study included 70 patients, aged 34-88 years, who were admitted to the Acute Coronary Care Unit with the ACS diagnosis.Result...

    Full description

    Subjects: Get full text
    Article
  15. 15

    MECHANISMS OF CARDIOVASCULAR DISEASES DEVELOPMENT IN OBESITY AND INSULIN RESISTANCE: FOCUS ON ATHEROTHROMBOSIS by V. N. Shishkova

    Published 2016-09-01

    Article takes into consideration pathogenetic mechanisms of cardiovascular diseases development  in obesity and insulin resistance, approaches to atherothrombotic complications prevention. The issues of resistance to antiplatelet drugs  are condsidered and possible  ways for its overcome.  The data ...

    Full description

    Subjects: Get full text
    Article
  16. 16

    Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease by N. V. Lomakin, I. Yu. Tkach, E. A. Shirokov

    Published 2025-03-01

    The course and complications of coronary artery disease (CAD) are associated with atherosclerosis progression and a high probability of atherothrombosis. Antithrombotic therapy is the most effective strategy for preventing cardiovascular events in atherosclerotic diseases. In accordance with current...

    Full description

    Subjects: Get full text
    Article
  17. 17

    CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES by P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian

    Published 2016-01-01

    Atherothrombosis is a complication of ischemic heart disease, and it leads to development of acute coronary syndrome. Atherothrombosis is characterized by sudden destruction of atherosclerotic plaque, which results into platelets activation and thrombus formation. Aspirin - one of the most widely us...

    Full description

    Subjects: Get full text
    Article
  18. 18

    ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS by L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo

    Published 2016-01-01

    Aim. To analyze the literary and own data about clopidogrel influence on platelets during inflammation and to reveal particularities of its usage in ischemic heart disease (IHD) patients with active inflammation. Material and methods. The platelet morphology and a number of leukocyte-platelet aggreg...

    Full description

    Subjects: Get full text
    Article
  19. 19

    THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS by E. A. Shelest, A. E. Shuganov, L. I. Patrushev, I. N. Bokarev

    Published 2015-09-01

    Aim. To study the intensity of the intravascular microcoagulation in patients with atherothrombosis (AT), chronic obstructive pulmonary disease (COPD) and thrombophilia.Material and methods. 115 patients were enrolled into the study: 37 patients with COPD (22 with thrombophilia and 15 without thromb...

    Full description

    Subjects: Get full text
    Article
  20. 20

    Prognosis of patients with coronary artery disease and diabetes — what to look for by A. A. Nekrasov, E. S. Timoshchenko, T. A. Nekrasova, E. V. Bakhrak

    Published 2024-10-01

    Patients with coronary artery disease (CAD) and diabetes are identified as a high cardiovascular risk group both in Russia and abroad. Having similar paths of development and progression of atherosclerosis and atherothrombosis, these diseases potentiate each other's thrombogenesis mechanisms. A...

    Full description

    Subjects: Get full text
    Article